ABCL ABCELLERA BIOLOGICS INC
2026Q1 · CUSIP 00288U106 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
135
Δ holders QoQ
-9
Breadth percentile
Top 85%
Whale holders
69
Δ whales
-7
Inst. holding value
$434M
New positions
19
Closed positions
28
Price momentum (1Q)
+31.2%
Put / Call
6/8
Breadth history (34 quarters)
Past Lit Events & Aftermath 4 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2022Q3 | Top 3% | -34.0% | -59.8% |
| 2022Q2 | Top 3% | +11.9% | -21.7% |
| 2021Q2 | Top 9% | -14.9% | -46.2% |
| 2021Q1 | Top 16% | -48.3% | -56.0% |
Options Sentiment
Put holders
6
QoQ: +1
Call holders
8
QoQ: +2
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-0.48
EPS YoY
—
Revenue (TTM)
$0.1B
Revenue YoY
+242.7%
Net margin
-181.7%
ROE
-15.3%
Debt ratio
28.2%
FCF (TTM)
-$189M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.